Idiopathic Juxtafoveal Telangiectasia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2016-11-22
Clinical Trial Update: Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel) [Phase 1]
Phase 1 safety trial of Ciliary Neurotrophic Factor (CNTF) in patients with macular telangiectasia completed.